Enliven Therapeutics ELVN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Enliven Therapeutics’s reported figures.
The official record: Enliven Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Enliven Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Enliven Therapeutics's enterprise value?
- Enliven Therapeutics (ELVN) reported enterprise value of $2.21B in Q1 2026.
- How has Enliven Therapeutics's enterprise value changed year-over-year?
- Enliven Therapeutics's enterprise value increased by 156.2% year-over-year, from $863.4M to $2.21B.
- What is the long-term trend for Enliven Therapeutics's enterprise value?
- Over 2 years (2021 to 2025), Enliven Therapeutics's enterprise value has grown at a 742.5% compound annual growth rate (CAGR), from $11.49M to $815.45M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.